Highlights
- Bajaj Healthcare shares climbed nearly 13% during Monday's trading session.
- Trading volume crossed 32 lakh shares with turnover above INR 111 crore.
- Stock remains below its 52-week high despite the sharp intraday rally.
Shares of Bajaj Healthcare Limited (NSE:BAJAJHCARE) witnessed sharp buying interest during the trading session on June 29, 2026, with the stock rising 12.78% to INR 342.90 as of 9:47 AM IST. The pharmaceutical company attracted significant trading activity, with investors tracking price movement following recent volatility in the healthcare space.
The stock opened at INR 313.00 against the previous close of INR 304.05 and climbed to an intraday high of INR 347.80. The day's low remained at the opening price of INR 313.00, indicating sustained buying throughout the early session.
Trading Activity Remains Elevated
Bajaj Healthcare recorded traded volume of 32.72 lakh shares, translating into traded value of approximately INR 111.72 crore. The stock's volume-weighted average price (VWAP) stood at INR 341.28.
The company's total market capitalisation was around INR 1,155.13 crore, while the free-float market capitalisation stood at INR 440.94 crore. Deliverable quantity accounted for 37.39% of total traded volume during the session.
The stock has an applicable margin rate of 22.73% and an impact cost of 0.15, reflecting active market participation.
Stock Performance Across Timeframes
Despite Monday's rally, Bajaj Healthcare has delivered mixed returns across different investment horizons.
The stock has gained 8.26% over the past week and advanced 13.83% over the past month. However, it remains down 18.99% on a year-to-date basis and has declined 33.78% over the last one year.
Over a three-year period, the stock has generated a return of 13.66%.
Source: NSE
Trading Range and Valuation
Bajaj Healthcare touched a 52-week high of INR 552.60 on July 15, 2025, while its 52-week low of INR 272.35 was recorded on May 18, 2026. At the current trading price, the stock continues to trade below its annual peak while remaining above the year's low.
The stock carries a symbol price-to-earnings (P/E) ratio of 48.03, while the adjusted P/E stands at 18.76. It has a face value of INR 5 per share and is listed in the pharmaceuticals industry segment.
The upper circuit limit for the trading session was INR 364.85, while the lower circuit limit was INR 243.25 under the 20% price band.
Recent Financial Performance
For the quarter ended March 31, 2026, Bajaj Healthcare reported standalone total income of INR 15,601.37 lakh.
The company reported a loss before tax of INR 2,080.88 lakh during the quarter. Net loss stood at INR 2,285.06 lakh, while earnings per share (EPS) came in at negative INR 6.08.
The financial results were released on May 8, 2026.
Key Risks
- Quarterly losses may affect earnings visibility going forward.
- Pharmaceutical sector remains subject to regulatory compliance requirements.
- Share price has remained volatile over the past year.
- Stock continues trading below its 52-week high.
Summary
Bajaj Healthcare shares rose 12.78% to INR 342.90 during early trade on June 29, 2026, supported by active market participation and turnover exceeding INR 111 crore. While the stock has posted gains over the past week and month, it remains below its 52-week high and has reported a standalone net loss for the quarter ended March 2026, highlighting mixed operational and market performance.
FAQs
Q: What was Bajaj Healthcare's share price on June 29, 2026?
A: Bajaj Healthcare traded at INR 342.90, up 12.78% from the previous closing price during early trading.
Q: How did Bajaj Healthcare perform in the March 2026 quarter?
A: The company reported standalone total income of INR 15,601.37 lakh and a net loss of INR 2,285.06 lakh.
Q: What is Bajaj Healthcare's 52-week trading range?
A: The stock has a 52-week high of INR 552.60 and a 52-week low of INR 272.35.